When somebody's coming in that has a known diagnosis of atopic dermatitis or eczema and things are really revved up still, if ...

In this video, Robert J. Smith, MD, discusses the many treatment options available to patients with atopic dermatitis.

Findings from a recent phase 3b/4 study of upadacitinib support a treat-to-target strategy for dose escalation or reduction ...

The antibody treatment could compete with Sanofi’s Dupixent and Eli Lilly’s Ebgylss, while offering the potential for less ...

Spongiotic dermatitis describes skin inflammation that causes swelling, redness, and itching. It's most often associated with ...

LEO Pharma has reported outcomes from the 16-week interim analysis of the Phase IIIb ADHAND trial of tralokinumab for hand atopic dermatitis (AD).

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Eczema Types: Atopic Dermatitis Diagnosis and Treatment -- A Guide for Patients – An American Academy of Dermatology Association Reading Room selection June 19, 2025 • 9 min read ...

Apogee Therapeutics, Inc.'s APG777 shows promising week-16 efficacy and dosing potential, targeting the AT market. Click for ...

About 15% of children in the United States develop atopic dermatitis. Almost all these pediatric patients are diagnosed by age 5, but more than half develop atopic dermatitis or "eczema" in the ...

Certain pain-related pruritus descriptors may independently predict mental health outcomes, sleep disturbance, and QOL reduction in patients with AD.

Nektar Therapeutics’ biologic drug rezpegaldesleukin takes a new approach to atopic dermatitis, or eczema, stimulating proliferation of immune cells that tamp down excessive immune responses ...